Deutsche Bank’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-4,427
| Closed | -$106K | – | 4420 |
|
2021
Q1 | $106K | Sell |
4,427
-403
| -8% | -$9.65K | ﹤0.01% | 3889 |
|
2020
Q4 | $143K | Buy |
4,830
+1,390
| +40% | +$41.2K | ﹤0.01% | 3575 |
|
2020
Q3 | $53K | Buy |
3,440
+836
| +32% | +$12.9K | ﹤0.01% | 3794 |
|
2020
Q2 | $65K | Buy |
2,604
+909
| +54% | +$22.7K | ﹤0.01% | 3618 |
|
2020
Q1 | $35K | Sell |
1,695
-103
| -6% | -$2.13K | ﹤0.01% | 3616 |
|
2019
Q4 | $54K | Buy |
1,798
+346
| +24% | +$10.4K | ﹤0.01% | 3827 |
|
2019
Q3 | $47K | Sell |
1,452
-2,482
| -63% | -$80.3K | ﹤0.01% | 3843 |
|
2019
Q2 | $125K | Sell |
3,934
-6,535
| -62% | -$208K | ﹤0.01% | 3975 |
|
2019
Q1 | $299K | Buy |
10,469
+3,946
| +60% | +$113K | ﹤0.01% | 3699 |
|
2018
Q4 | $261K | Sell |
6,523
-4,787
| -42% | -$192K | ﹤0.01% | 3649 |
|
2018
Q3 | $527K | Buy |
11,310
+1,522
| +16% | +$70.9K | ﹤0.01% | 3703 |
|
2018
Q2 | $805K | Buy |
+9,788
| New | +$805K | ﹤0.01% | 3540 |
|
2018
Q1 | – | Sell |
-172
| Closed | -$5K | – | 4862 |
|
2017
Q4 | $5K | Buy |
172
+170
| +8,500% | +$4.94K | ﹤0.01% | 4348 |
|
2017
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 4356 |
|
2017
Q2 | $0 | Sell |
2
-1,455
| -100% | – | ﹤0.01% | 4459 |
|
2017
Q1 | $20K | Sell |
1,457
-1,833
| -56% | -$25.2K | ﹤0.01% | 4148 |
|
2016
Q4 | $37K | Buy |
3,290
+3,288
| +164,400% | +$37K | ﹤0.01% | 4123 |
|
2016
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 4455 |
|
2016
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4740 |
|
2013
Q4 | – | Sell |
-24
| Closed | – | – | 4926 |
|
2013
Q3 | $0 | Buy |
+24
| New | – | ﹤0.01% | 5044 |
|